|
（単位：百万ドル）
|
2011/6
|
2012/6
|
2013/6
|
2014/6
|
2015/6
|
2016/6
|
2017/6
|
2018/6
|
2019/6
|
2020/6
|
2021/6
|
2022/6
|
2023/6
|
2024/6
|
2025/6
|
|
売上高
|
1,243
|
1,368
|
1,514
|
1,554
|
1,678
|
1,838
|
2,066
|
2,340
|
2,607
|
2,957
|
3,197
|
3,578
|
4,223
|
4,685
|
5,146
|
|
売上成長率（％）
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
売上原価
|
501
|
547
|
573
|
565
|
667
|
772
|
864
|
978
|
1,069
|
1,239
|
1,357
|
1,553
|
1,867
|
2,029
|
2,091
|
|
売上総利益
|
741
|
820
|
940
|
989
|
1,011
|
1,066
|
1,201
|
1,362
|
1,536
|
1,717
|
1,839
|
2,024
|
2,356
|
2,655
|
3,055
|
|
売上総利益率（％）
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
研究開発費
|
92
|
109
|
120
|
118
|
114
|
118
|
144
|
155
|
180
|
201
|
225
|
253
|
287
|
307
|
331
|
|
販売管理費
|
371
|
401
|
430
|
450
|
478
|
488
|
553
|
600
|
645
|
676
|
670
|
739
|
874
|
917
|
991
|
|
営業費用
|
474
|
526
|
585
|
584
|
602
|
637
|
775
|
820
|
957
|
908
|
935
|
1,024
|
1,223
|
1,335
|
1,369
|
|
営業利益
|
266
|
294
|
354
|
405
|
409
|
428
|
425
|
541
|
579
|
809
|
903
|
1,000
|
1,131
|
1,319
|
1,685
|
|
営業利益率 (%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
経常（税引前）利益
|
303
|
331
|
385
|
431
|
435
|
439
|
418
|
521
|
518
|
733
|
883
|
960
|
1,101
|
1,264
|
1,677
|
|
経常（税引前）利益率（％）
|
24.43
|
24.26
|
25.43
|
27.72
|
25.96
|
23.91
|
20.26
|
22.28
|
19.91
|
24.79
|
27.64
|
26.84
|
26.09
|
27.0
|
32.6
|
|
法人税等合計
|
76
|
77
|
77
|
85
|
83
|
87
|
76
|
205
|
114
|
111
|
409
|
181
|
204
|
243
|
276
|
|
実効税率（％）
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
純利益
|
226
|
254
|
307
|
345
|
352
|
352
|
342
|
315
|
404
|
621
|
474
|
779
|
897
|
1,020
|
1,400
|
|
純利益率（％）
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
一株あたり利益
|
1.49
|
1.75
|
2.15
|
2.44
|
2.51
|
2.51
|
2.42
|
2.21
|
2.83
|
4.31
|
3.27
|
5.34
|
6.12
|
6.94
|
9.55
|
|
希薄化後一株あたり利益
|
1.44
|
1.71
|
2.1
|
2.39
|
2.47
|
2.49
|
2.4
|
2.19
|
2.8
|
4.27
|
3.24
|
5.3
|
6.09
|
6.92
|
9.51
|
|
配当性向（%）
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
一株あたり配当金
|
-
|
-
|
0.68
|
1
|
1.12
|
1.2
|
1.32
|
1.4
|
1.48
|
1.56
|
1.56
|
1.68
|
1.76
|
1.92
|
2.12
|
|
EBITDA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDAマージン（％）
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|